Diamond Eagle is still a question mark…it doesn’t want to leave the nest.
Health Sciences (HSAC) is expected to price their SPAC tonight and possibly Diamond Eagle (DEAC) too. However, Diamond Eagle, Jeff Sagansky’s fifth “Eagle”, was widely reported to be pricing last night, but sometimes the calendar (and the SEC) have other plans. So what are the odds it prices? 50/50 shot. The underwriters will make every effort, but it’s a toss up if they haven’t cleared with the SEC yet.
On the other hand, Health Sciences, the RTW Investments-backed SPAC focusing on BioPharma and Med Tech companies in North America and Europe, is pretty much a lock to go asap. HSAC, while SPAC newbies, has a compelling sector focus and the sponsor and management team are strong. Consequently, there should be significant demand for this deal. Especially since it’s a smaller size at $100 million. Allocations should be tight so look for this one to trade well right out of the gate.
As a reminder, a summary of terms for both SPACs is provided below:
At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...